EA201390787A1 - Способ получения метаксалона - Google Patents
Способ получения метаксалонаInfo
- Publication number
- EA201390787A1 EA201390787A1 EA201390787A EA201390787A EA201390787A1 EA 201390787 A1 EA201390787 A1 EA 201390787A1 EA 201390787 A EA201390787 A EA 201390787A EA 201390787 A EA201390787 A EA 201390787A EA 201390787 A1 EA201390787 A1 EA 201390787A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- solvent
- tgic
- specified
- dielectric constant
- range
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Изобретение относится к способу получения метаксалона, включающему взаимодействие триглицидилизоцианурата (TGIC) с м-ксиленолом, отличающемуся тем, что вышеуказанную реакцию проводят в смеси растворителей, содержащей апротонный полярный растворитель с диэлектрической проницаемостью, большей или равной 30, и по меньшей мере один другой растворитель, выбранный из группы, состоящей из неполярных растворителей и апротонных полярных растворителей с диэлектрической проницаемостью ниже 30, притом что вышеуказанная смесь растворителей содержит от 5 до 40 вес.% указанного первого растворителя и от 95 до 60 вес.% указанного второго растворителя, добавляя TGIC при температуре в интервале от 30 до 50°С и после добавления TGIC повышая температуру реакционного раствора до значения в интервале от 80 до 180°С в течение промежутка времени от 120 до 180 мин при скорости увеличения не выше чем 1,25°С/мин. Изобретение также относится к метаксалону с пониженным содержанием примесей, получающихся в результате незавершенных реакций и/или побочных реакций, соответствующих способу получения.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11152849 | 2011-02-01 | ||
| US201161439127P | 2011-02-03 | 2011-02-03 | |
| PCT/EP2012/050609 WO2012104139A1 (en) | 2011-02-01 | 2012-01-17 | Method of preparation of metaxalone |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA201390787A1 true EA201390787A1 (ru) | 2013-11-29 |
| EA024417B1 EA024417B1 (ru) | 2016-09-30 |
Family
ID=44115617
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201390787A EA024417B1 (ru) | 2011-02-01 | 2012-01-17 | Способ получения метаксалона |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US20130261160A1 (ru) |
| EP (1) | EP2670737B1 (ru) |
| JP (1) | JP2014503564A (ru) |
| KR (1) | KR101907599B1 (ru) |
| CN (1) | CN103298797B (ru) |
| AR (1) | AR084946A1 (ru) |
| AU (1) | AU2012213666B2 (ru) |
| BR (1) | BR112013013134B1 (ru) |
| CA (1) | CA2817462C (ru) |
| CY (1) | CY1118348T1 (ru) |
| DK (1) | DK2670737T3 (ru) |
| EA (1) | EA024417B1 (ru) |
| ES (1) | ES2605425T3 (ru) |
| GE (1) | GEP20156352B (ru) |
| HK (1) | HK1191006A1 (ru) |
| HR (1) | HRP20161660T1 (ru) |
| HU (1) | HUE029476T2 (ru) |
| IL (1) | IL226329A (ru) |
| LT (1) | LT2670737T (ru) |
| MX (1) | MX339346B (ru) |
| PL (1) | PL2670737T3 (ru) |
| PT (1) | PT2670737T (ru) |
| SG (2) | SG192090A1 (ru) |
| SI (1) | SI2670737T1 (ru) |
| SM (1) | SMT201600415B (ru) |
| UA (1) | UA114593C2 (ru) |
| WO (1) | WO2012104139A1 (ru) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102181881B1 (ko) | 2014-11-21 | 2020-11-24 | 삼성디스플레이 주식회사 | 비전 검사 장치 및 이의 감마 및 얼룩 보정 방법 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1545951A1 (de) * | 1965-07-24 | 1970-05-14 | Henkel & Cie Gmbh | Verfahren zur Herstellung von substituierten Oxazolidonen |
| FR1487641A (fr) | 1965-07-24 | 1967-07-07 | Henkel & Cie Gmbh | Procédé de préparation d'oxazolidones substituées |
| WO2003061552A2 (en) * | 2002-01-14 | 2003-07-31 | Sun Pharmaceutical Industries Limited | Novel process for the preparation of substantially pure 5-(3,5-dimethylphenoxy)methyl-2-oxazolidinone |
| US6562980B1 (en) * | 2002-08-19 | 2003-05-13 | Yung Shin Pharma Ind. Co., Ltd. | Method for producing 5-aryloxymethyl-2-oxazolidinones |
| WO2007074477A2 (en) * | 2005-12-29 | 2007-07-05 | Dabur Pharma Limited | Metaxalone polymorphs |
| WO2008006096A1 (en) | 2006-07-07 | 2008-01-10 | Boehringer Ingelheim Chemicals, Inc. | Metaxalone synthesis |
| CN101921241A (zh) * | 2009-06-12 | 2010-12-22 | 北京京卫燕康药物研究所有限公司 | 具有光学活性的美他沙酮的合成 |
-
2012
- 2012-01-17 EA EA201390787A patent/EA024417B1/ru unknown
- 2012-01-17 SG SG2013055991A patent/SG192090A1/en unknown
- 2012-01-17 PL PL12700288T patent/PL2670737T3/pl unknown
- 2012-01-17 HU HUE12700288A patent/HUE029476T2/en unknown
- 2012-01-17 ES ES12700288.9T patent/ES2605425T3/es active Active
- 2012-01-17 GE GEAP201213202A patent/GEP20156352B/en unknown
- 2012-01-17 DK DK12700288.9T patent/DK2670737T3/en active
- 2012-01-17 SG SG10201600357WA patent/SG10201600357WA/en unknown
- 2012-01-17 UA UAA201305952A patent/UA114593C2/uk unknown
- 2012-01-17 EP EP12700288.9A patent/EP2670737B1/en active Active
- 2012-01-17 AU AU2012213666A patent/AU2012213666B2/en active Active
- 2012-01-17 US US13/990,974 patent/US20130261160A1/en not_active Abandoned
- 2012-01-17 BR BR112013013134-9A patent/BR112013013134B1/pt active IP Right Grant
- 2012-01-17 WO PCT/EP2012/050609 patent/WO2012104139A1/en active Application Filing
- 2012-01-17 PT PT127002889T patent/PT2670737T/pt unknown
- 2012-01-17 SI SI201230789A patent/SI2670737T1/sl unknown
- 2012-01-17 CN CN201280004303.XA patent/CN103298797B/zh active Active
- 2012-01-17 LT LTEP12700288.9T patent/LT2670737T/lt unknown
- 2012-01-17 KR KR1020137016255A patent/KR101907599B1/ko active IP Right Grant
- 2012-01-17 CA CA2817462A patent/CA2817462C/en active Active
- 2012-01-17 MX MX2013008426A patent/MX339346B/es active IP Right Grant
- 2012-01-17 JP JP2013550823A patent/JP2014503564A/ja active Pending
- 2012-01-30 AR ARP120100285A patent/AR084946A1/es active IP Right Grant
-
2013
- 2013-05-13 IL IL226329A patent/IL226329A/en active IP Right Grant
-
2014
- 2014-04-30 HK HK14104176.2A patent/HK1191006A1/zh unknown
-
2015
- 2015-06-17 US US14/742,203 patent/US9416116B2/en active Active
-
2016
- 2016-11-15 SM SM201600415T patent/SMT201600415B/it unknown
- 2016-12-01 CY CY20161101242T patent/CY1118348T1/el unknown
- 2016-12-06 HR HRP20161660TT patent/HRP20161660T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2014366334B2 (en) | Mono- and dialkyl ethers of furan-2,5-dimethanol and (tetra-hydrofuran-2,5-diyl)dimethanol and amphiphilic derivatives thereof | |
| EP2578533A4 (en) | ALKALIMETAL SALT FROM FLUOROSULPHONYLIMIDE AND METHOD OF MANUFACTURING THEREOF | |
| EA201990688A1 (ru) | Полиморфные формы соединения, представляющего собой ингибитор киназ, содержащая их фармацевтическая композиция, способ их получения и их применение | |
| EA202192581A1 (ru) | Композиции d-метирозина и способы их получения | |
| MX2022001495A (es) | Procesos novedosos para preparar estimuladores de guanilato ciclasa soluble. | |
| WO2015156703A3 (en) | Functional metallosiloxanes, products of their partial hydrolysis and their use | |
| DE112007001452A5 (de) | Verfahren zur Herstellung von wasserstoffreichen Cyclosiloxanen | |
| EA201390787A1 (ru) | Способ получения метаксалона | |
| JOP20180126A1 (ar) | عمليات جديدة من أجل تحضير منشطات محلقة غوانيلات قابلة للذوبان | |
| WO2011107843A3 (en) | Process for the preparation of atazanavir sulfate substantially free of diastereomers | |
| MX2023000044A (es) | Nuevos procesos e intermediarios para la preparacion de estimulantes de guanilato ciclasa soluble. | |
| MX2017004383A (es) | Proceso para preparar 1-(3,5-diclorofenil)-2,2,2-trifluoroetanona y sus derivados. | |
| RU2015135184A (ru) | Способ получения соединения пиридазинона и промежуточных продуктов для его получения | |
| MY196769A (en) | Synthesis of a thiosulfonic acid by a step of periodate mediated oxidative coupling of a thiosulfonic acid with an aniline | |
| EA201991887A1 (ru) | Замещенные эфиры бензил-4-аминопиколиновой кислоты и эфиры пиримидин-4-карбоновой кислоты, способы их получения, а также их применение в качестве гербицидов и регуляторов роста | |
| MX349740B (es) | Proceso para la preparacion de fenilpropanonas sustituidas. | |
| EA201690757A1 (ru) | Способ получения промежуточного соединения иопромида | |
| RU2013122379A (ru) | Способ синтеза дротаверина | |
| PL407902A1 (pl) | Nowe P-winylobenzyle oraz sposób ich otrzymywania | |
| MX2019006224A (es) | Proceso para la preparacion de acetoacetato de n-bencil-n-metiletanolamina mediante la transesterificacion de cetoesteres libre de catalizadores. | |
| RU2014118603A (ru) | Жидкие смеси стабилизаторов | |
| US9884764B2 (en) | Purification of phosphorus decasulfide (P4S10) | |
| RU2016134724A (ru) | Способ получения очищенного соединения | |
| NZ625000A (en) | Co-crystals of cyprodinil | |
| UA107093C2 (ru) | СПОСОБ ПОЛУЧЕНИЯ АРГЕНТУМ(I)ПЕНТАТИОТАНТАЛАТУ(V)ЙОДИДА Ag6TaS5I |